Gilead acquisition of Immunomedics : Pharma giant to gain access to breast cancer drug Trodelvy

Gilead acquisition of Immunomedics : US pharma giant Gilead Sciences has signed a $21 billion worth deal to acquire New Jersey-based biopharma company Immunomedics to ... Read More